Optimization of Genome Editing Therapeutics for Alzheimer's Disease-Related Dementias (ADRD) (U01 - Clinical Trials Not Allowed)
This funding opportunity supports the development of genome editing therapies for Alzheimer's-related dementias (ADRD). It focuses on improving promising therapeutic leads, preparing them for further studies needed before clinical trials. The goal is to optimize candidates with proven effectiveness, ability to be manufactured, distributed in the body, and effectively engage targets. The grant …
This Notice of Funding Opportunity (NOFO) supports the optimization of promising genome editing-based therapeutic leads for Alzheimer's Disease-Related Dementias (ADRD), towards IND-enabling studies. Specifically, it supports the characterization and optimization of therapeutic lead(s) that show…
Funding Source
Awards & funding
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers